Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bausch and Lomb acquires eye drops brand

Bausch and Lomb acquires eye drops brand

6th August 2007

Bausch & Lomb has announced the purchase from Alimera Sciences of the Soothe emollient eye drop brand, with the financial terms of the agreement remaining undisclosed.

Following this acquisition, the company will introduce a wider line of over-the-counter products professionally-recommended by healthcare professionals for the relief of dry-eye symptoms.

Initially, Bausch & Lomb reports that it will focus on two technologies in this area, each targeted on a different tear film layer.

Soothe was first launched in 2004, before being renamed as Soothe XP and was the first multi-dose over-the-counter emollient-based artificial tear product on the market.

Its unique makeup facilitates the re-establishment of the protective lipid layer of the eye to seal in moisture and reduce tear evaporation.

Gary Phillips, corporate vice-president and global pharmaceutical category leader at Bausch & Lomb, said: “The Soothe brand acquisition further strengthens our portfolio and provides a first-rate platform for further line extensions in this fast-growing segment of the ophthalmic industry.”

He added that the company is continuing to expand its over-the-counter line of products.

Last month, Bausch & Lomb announced the launch of the Ocuvite DF eye vitamen supplement aimed at maintaining eye health in patients with diabetes.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.